# GEKO Venous Thromboembolism Prevention Study

Study · id `cardio:ct-nct05476913` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05476913](<https://clinicaltrials.gov/study/NCT05476913>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05476913

Browse, organ or system: Heart; Blood vessels; Brain  
Browse, condition area: Coronary and vascular disease; Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT05476913. Randomized; single masking; primary purpose prevention. Start 2023-07-06 (actual); primary completion 2025-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT05476913, source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)
- Started: 2023-07-06 (actual) (ClinicalTrials.gov record NCT05476913, source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)
- Primary completion: 2025-04-30 (anticipated) (ClinicalTrials.gov record NCT05476913, source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)
- Completion: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT05476913, source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05476913, source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05476913-2025-03-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: GEKO Venous Thromboembolism Prevention Study
- Condition: Stroke, Acute
- Condition: Venous Thromboembolism
- Condition: Deep Vein Thrombosis
- Condition: Pulmonary Embolism
- Intervention (Device): geko™ device
- Lead sponsor: Firstkind Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: National Institute for Health Research, United Kingdom
- Collaborator class: OTHER\_GOV
- Collaborator: Keele University
- Collaborator class: OTHER
- Collaborator: University Hospitals of North Midlands NHS Trust
- Collaborator class: OTHER
- Collaborator: University of California
- Collaborator class: OTHER
- Collaborator: Bournemouth University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: National Institute for Health Research, United Kingdom (`cardio:org-national-institute-for-health-research-united-kingdom`)

## Provenance

Content hash: f96c8fe705f77e2f5fe4663804f7e94a0c815253d4235b851994e39d049584f6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
